AK

Amit Kumar

Active Director Director DIN 10184488
DIN 10184488 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Amit Kumar

Data last updated:

Amit Kumar is a Director at Pinewave Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Pinewave Pharmaceuticals Private Limited reported revenue of ₹6.4 Lakh (FY 2025).

DIN 10184488
Primary Designation Director
Industry Pharma
First Appointment 31 May 2023
Oldest Company Age 3 yrs
Largest company Pinewave Pharmaceuticals Private Limited · ₹6.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 May 20232023₹6.4 Lakh (FY 2025)Active

Board colleagues of Amit Kumar

NameDINCompanyDesignation
Bharat Bhushan10184487Pinewave Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pinewave Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Kumar

Amit Kumar currently holds 1 directorship: Pinewave Pharmaceuticals Private Limited (Director, since 31 May 2023, revenue ₹6.4 Lakh (FY 2025)).

Amit Kumar was first appointed on 31 May 2023 as Director at Pinewave Pharmaceuticals Private Limited.

The current boards of Amit Kumar's companies include Bharat Bhushan (Pinewave Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available